Women's Hair Loss in NYC: Causes, Treatment Options, and When to Seek Help

Hair loss is often portrayed as a predominantly male concern. The reality is strikingly different: approximately 40% of women will experience noticeable hair thinning by age 50, and for many, the experience begins decades earlier. Unlike the well-characterized Norwood scale used for male pattern baldness, female hair loss presents in more diffuse and varied patterns — often making it harder to diagnose, easier to dismiss, and more emotionally distressing for the women experiencing it.

At Regen Health Physicians NYC, Dr. Ajit Dhaliwal and our clinical team specialize in identifying the precise cause of women's hair loss and designing evidence-based treatment protocols that address both local follicular health and the underlying systemic contributors. Our precision hair restoration program is fully tailored to the unique biology of female hair loss.

Why Female Hair Loss Is Different

Men with androgenetic alopecia typically lose hair in a predictable pattern — receding at the temples, thinning at the crown — because DHT (dihydrotestosterone) preferentially affects follicles in those zones.

Women experience hair loss differently:

• Pattern: Usually diffuse thinning across the entire crown and top of the scalp (Ludwig pattern), with the hairline generally preserved
• Hormonal complexity: Multiple hormonal axes influence female hair biology — not just androgens, but estrogen, progesterone, thyroid, cortisol, and prolactin
• More diverse causes: Women's hair loss is more frequently multifactorial, with nutritional, autoimmune, and stress-related contributors playing larger roles than in men
• Emotional impact: Hair holds significant identity and psychological weight for many women; the distress associated with thinning often exceeds what an observer would estimate from looking at the scalp

Common Causes of Hair Loss in Women

1. Female Pattern Hair Loss (FPHL / Androgenetic Alopecia)

The most common form of women's hair loss, FPHL affects an estimated 30 million American women. While androgens play a role — particularly in women who are genetically predisposed to DHT sensitivity in scalp follicles — estrogen levels matter too: the significant post-menopausal drop in estrogen unmasks follicular androgen sensitivity in many women.

FPHL tends to progress gradually. Early intervention produces the best outcomes.

2. Postpartum Hair Loss (Telogen Effluvium)

Approximately 40–50% of women experience significant hair shedding 2–4 months after delivery. During pregnancy, elevated estrogen extends the anagen (growth) phase, leading to lush, full hair. After delivery, estrogen drops sharply and the follicles enter telogen (rest) simultaneously — triggering synchronized shedding. This is physiologically normal but can be alarming in volume.

Most postpartum hair loss resolves within 6–12 months. For women with prolonged shedding, concurrent iron deficiency, thyroid dysfunction, or FPHL unmasked by the pregnancy should be evaluated.

3. Thyroid Dysfunction

Both hypothyroidism and hyperthyroidism can cause diffuse hair thinning. Thyroid hormones regulate the hair follicle cell cycle; disruption at either end of the spectrum leads to premature follicular regression. Importantly, even treated hypothyroidism with suboptimal TSH levels can perpetuate hair loss. Evaluation should include full thyroid panels, not just TSH.

4. Iron Deficiency

Low ferritin — the body's iron storage protein — is one of the most commonly missed contributors to female hair loss. Serum iron and hemoglobin may be normal while ferritin is depleted. Research suggests ferritin levels below 70 ng/mL may impair hair growth; many women with hair loss test in the 20–40 range. Optimizing ferritin is often one of the most impactful interventions available.

5. Hormonal Imbalances Beyond Thyroid

Elevated prolactin, polycystic ovarian syndrome (PCOS) with androgen excess, insulin resistance, and adrenal dysfunction all contribute to female hair loss. Our chronic disease and hormone management program evaluates these axes as part of every comprehensive hair loss workup.

6. Alopecia Areata

An autoimmune condition in which immune cells attack hair follicles, alopecia areata presents as patchy, often circular areas of complete hair loss rather than diffuse thinning. It can affect the scalp, brows, lashes, and body hair. Treatment options differ significantly from androgenetic alopecia.

7. Chronic Stress and Lifestyle

Significant psychological or physiological stressors — including major illness, rapid weight loss, surgery, or sustained chronic stress — can trigger telogen effluvium. Correcting the stressor, supporting adrenal function, and optimizing nutritional status are central to recovery.

How RHPNY Evaluates Women's Hair Loss

Dr. Dhaliwal's evaluation approach for female hair loss is comprehensive by design. A surface-level look at the scalp without exploring systemic contributors routinely misses the most treatable causes.

Our workup typically includes:

• Scalp dermoscopy — magnified evaluation of follicular miniaturization, perifollicular fibrosis, and hair shaft abnormalities
• Complete hormonal panel — TSH, free T3/T4, testosterone (total and free), DHEA-S, LH/FSH, prolactin, estradiol, progesterone
• Nutritional markers — ferritin, zinc, vitamin D, B12, folate, omega-3 index
• Inflammatory and metabolic markers — CBC, CMP, hs-CRP, fasting insulin
• Medical and medication history — many common medications cause or worsen hair loss

Treatment Approaches at RHPNY

PRP Hair Restoration for Women

Platelet-Rich Plasma therapy is among our most effective first-line treatments for FPHL and telogen effluvium with active follicles. PRP concentrates growth factors that extend the anagen phase, improve scalp microcirculation, and reverse follicular miniaturization. Clinical studies in female patients have demonstrated significant improvements in hair density and shaft diameter after a series of treatments.

Women who start PRP earlier in the progression of FPHL consistently achieve better outcomes. Waiting until follicles are completely lost removes the therapeutic window.

Nutritional and Hormonal Correction

Optimizing ferritin, thyroid function, and sex hormones is often the single most impactful intervention for women with nutritional or hormonal drivers. Dr. Dhaliwal prescribes targeted nutritional repletion and, where appropriate, hormone therapy based on a patient's full clinical picture.

Topical and Oral Adjuncts

Evidence-supported adjunctive options — including topical minoxidil, low-level laser therapy (LLLT), and nutraceutical protocols — are integrated into treatment plans where appropriate. These are selected based on the individual's diagnosis and tolerability, not applied as a blanket protocol.

Peptide Support

Select peptide therapies that support tissue repair, reduce inflammation, and optimize hormonal signaling may be incorporated into hair restoration protocols for appropriate patients.

When Should You Seek Evaluation?

The earlier, the better. Hair loss is significantly easier to arrest and reverse when follicles are still present and miniaturized — as opposed to fully lost. If you notice increased shedding, widening of your part line, a change in ponytail diameter, or visible scalp on the crown, that is the right moment to act.

Book a consultation at RHPNY to receive a thorough evaluation of your hair loss, identify any correctable contributing factors, and start a tailored treatment plan. We serve women across New York City and Salt Lake City.

---

Medical Disclaimer: This article is for educational purposes only. Hair loss has multiple potential causes and requires individualized medical evaluation. Information presented here does not constitute medical advice. Please consult a qualified physician for diagnosis and treatment recommendations.